LAS VEGAS, NV–(Marketwired – May 5, 2015) – Trinity Pharma Solutions, a leader in cloud-based data and guided analytics solutions for the global life sciences industry, today announced a record year serving the specialty pharmaceutical sector with a significant number of new clients and triple-digit growth. Trinity’s Specialty solution delivers integrated analytics across the organization to deliver intelligent insights regarding critical patient, physician, and payer interactions to drive successful launch and revenue growth for specialty pharmaceuticals. As a sponsor of this week’s Armada 2015 Specialty Summit, the company will be part of the dialogue around the most critical issues facing this rapidly expanding healthcare segment, poised to grow to $236 billion in 2017.
“Trinity Pharma is helping our specialty pharma clients transform their data into actionable healthcare insights in real time,” offered Zackary King, Founder and CEO of Trinity Pharma Solutions. “Successful commercialization requires a dynamic approach to ensure the right patients are able to access these treatments. This is where Trinity Pharma’s Specialty analytics come in — addressing the critical challenges for launching and growing specialty therapeutics sales.”
Trinity Pharma’s Specialty solution enables pharmaceutical and biotechnology firms to maximize the potential of one of the fastest growing segments of the market — specialty drugs. Companies can drive performance by better understanding potential patient populations and physician prescribing behavior for specialty drugs. Specifically, Trinity Pharma’s Specialty solution delivers:
- Real-time analytic workflow, health system insights and predictive analytics on physician and patient populations
- Guided insights into treatment preferences across healthcare settings, patient and physician dynamics
- Deep and up-to-the-minute understanding of behavioral influence and utilization patterns
In one case, Trinity Pharma’s Specialty solution was used by a specialty pharma company for the launch of two new innovative therapies into the infectious diseases market. The sales team needed the data to accurately and effectively represent very specialized products across a wide range of distribution channels. It was critical for the company to find a single data and analytics system with the specific therapeutic expertise to support the launch in a demanding timeframe. Armed with accurate, specialized data sets and innovative analytics via the Trinity Pharma’s Specialty solution, the company was able to ensure the therapies’ launch success. A constant feedback loop of performance data continues to provide sales leadership with the intelligence they need to capitalize on new opportunities.
About Trinity Pharma
Trinity Pharma is the leader in cloud-based data and mobile analytics solutions for global life sciences. The company delivers smarter, timelier access to novel insights that provide new ways to look at the healthcare business to increase competitiveness, enhance customer engagement and grow revenue. Purpose-built for the life sciences industry, Trinity’s Enterprise Cloud Analytics Platform is the fastest way to transform healthcare data into actionable insights and achieve significant scale and agility. More information can be found at www.trinitypharmasolutions.com.